Correct Answer: D. Betamethasone
Betamethasone is the gold-standard corticosteroid for fetal lung maturation in preterm labor because it has superior placental transfer and proven neonatal benefit. The mechanism involves acceleration of surfactant synthesis (phospholipids like lecithin and sphingomyelin) in fetal type II pneumocytes, reducing respiratory distress syndrome (RDS) risk by 50% and neonatal mortality by 30%. Betamethasone's long half-life (~36–54 hours), high lipophilicity, and minimal placental metabolism allow adequate fetal exposure. The standard Indian DOC regimen is betamethasone 12 mg IM given as two doses 24 hours apart, administered between 24–34 weeks gestation (or up to 36+6 weeks in select cases per FIGO/RCOG guidelines adapted in India). Unlike hydrocortisone (short-acting, poor placental transfer) or methylprednisolone (rapid metabolism), betamethasone achieves sustained fetal levels. Triamcinolone, though long-acting, has less robust RCT evidence and is not recommended for this indication in Indian obstetric practice. The ACOG and Indian guidelines (adapted by FOGSI) endorse betamethasone or dexamethasone (alternative) as first-line agents.
Why the other options are wrong
A. Triamcinolone — Although triamcinolone is long-acting, it lacks robust randomized controlled trial evidence for fetal lung maturation compared to betamethasone. Indian obstetric guidelines (FOGSI) do not recommend triamcinolone as first-line for this indication. It is rarely used in preterm labor management in India. B. Methylprednisolone — Methylprednisolone has poor placental transfer and rapid hepatic metabolism, resulting in inadequate fetal exposure. Its short half-life (3–4 hours) makes it unsuitable for sustained fetal lung maturation. Indian obstetric practice does not use methylprednisolone for this indication; it is reserved for other maternal indications (e.g., autoimmune conditions). **C. Hydrocortisone** — Hydrocortisone is rapidly metabolized by placental 11β-hydroxysteroid dehydrogenase, resulting in minimal fetal bioavailability. Its short half-life (8–12 hours) and weak glucocorticoid potency make it ineffective for fetal lung maturation. It is used only for maternal adrenal insufficiency, not for fetal benefit.
High-Yield Facts
- Betamethasone 12 mg IM × 2 doses (24 hours apart) is the standard Indian DOC for fetal lung maturation in preterm labor (24–34 weeks).
- Mechanism: Accelerates surfactant synthesis in fetal type II pneumocytes, reducing RDS risk by 50% and neonatal mortality by 30%.
- Betamethasone vs. hydrocortisone: Betamethasone has high placental transfer and long half-life (~36–54 hours); hydrocortisone is rapidly inactivated by placental 11β-HSD and has poor fetal bioavailability.
- Dexamethasone (6 mg IM × 4 doses, 12 hours apart) is an acceptable alternative in India when betamethasone is unavailable.
- Repeat courses are NOT routinely recommended in Indian guidelines; single course is standard unless delivery delayed >7 days (individualized reassessment).
Mnemonics
BETA for Betamethasone (Fetal Lung) Betamethasone = Best for fetal Benefits; Excellent placental transfer; Two doses; Accelerates surfactant. Use when counseling preterm labor patients on antenatal corticosteroid options. Placental Metabolism Rule Hydrocortisone = Inactivated by placental 11β-HSD (poor fetal access). Betamethasone/Dexamethasone = Resistant to 11β-HSD (good fetal access). Remember: 'Hydro = Hydrogenated away by placenta.'
NBE Trap
NBE may pair triamcinolone or methylprednisolone with "long-acting" or "potent" descriptors to distract from the specific evidence base for fetal lung maturation. The trap is confusing general corticosteroid properties with proven neonatal benefit in preterm labor.
Clinical Pearl
In Indian tertiary centers, a woman presenting with preterm labor at 28 weeks receives betamethasone 12 mg IM stat, then 12 mg IM 24 hours later. This single course reduces neonatal RDS by half and is standard of care across FOGSI-affiliated hospitals. Delayed delivery (even by 48 hours) allows maximal fetal benefit.
_Reference: KD Tripathi Pharmacology Ch. 13 (Corticosteroids); DC Dutta Obstetrics Ch. 23 (Preterm Labor); FOGSI Guidelines on Preterm Labor Management_